Post-approval studies (Phase 4)Study completedNCT03761277
What this trial is testing
Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain
Who this might be right for
Chronic Non-malignant PainChronic PainPain, Back+1 more
MedtronicNeuro 93